246 related articles for article (PubMed ID: 32346759)
61. Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial.
Kuhlen M; Willasch AM; Dalle JH; Wachowiak J; Yaniv I; Ifversen M; Sedlacek P; Guengoer T; Lang P; Bader P; Sufliarska S; Balduzzi A; Strahm B; von Luettichau I; Hoell JI; Borkhardt A; Klingebiel T; Schrappe M; von Stackelberg A; Glogova E; Poetschger U; Meisel R; Peters C
Br J Haematol; 2018 Jan; 180(1):82-89. PubMed ID: 29193007
[TBL] [Abstract][Full Text] [Related]
62. Predictors of Vertebral Deformity in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia: The PETALE Study.
Fiscaletti M; Samoilenko M; Dubois J; Miron MC; Lefebvre G; Krajinovic M; Laverdière C; Sinnett D; Alos N
J Clin Endocrinol Metab; 2021 Jan; 106(2):512-525. PubMed ID: 33150433
[TBL] [Abstract][Full Text] [Related]
63. A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia.
Li QB; Li L; You Y; Chen ZC; Xia LH; Zou P
Acta Pharmacol Sin; 2009 Oct; 30(10):1471-8. PubMed ID: 19767767
[TBL] [Abstract][Full Text] [Related]
64. Long-term brain status and cognitive impairment in children treated for high-risk acute lymphoblastic leukemia with and without allogeneic hematopoietic stem cell transplantation: A single-center study.
Zając-Spychała O; Pawlak MA; Karmelita-Katulska K; Pilarczyk J; Jończyk-Potoczna K; Przepióra A; Derwich K; Pieczonka A; Wachowiak J
Pediatr Blood Cancer; 2020 Jun; 67(6):e28224. PubMed ID: 32196935
[TBL] [Abstract][Full Text] [Related]
65. Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia.
Zheng C; Zhu X; Tang B; Yao W; Song K; Tong J; Geng L; Liu H; Sun Z
Ann Hematol; 2015 Mar; 94(3):473-80. PubMed ID: 25217231
[TBL] [Abstract][Full Text] [Related]
66. Outcome of patients less than 55 years of age with high-risk acute leukemia who did not have an human leukocyte antigen-identical related donor: a long-term study of 97 consecutive patients.
Cornillon J; Fawaz A; Depil S; Dufosse F; Duhamel A; Bauters F; Fenaux P; Jouet JP; Yakoub-Agha I
Leuk Lymphoma; 2005 Jun; 46(6):841-9. PubMed ID: 16019528
[TBL] [Abstract][Full Text] [Related]
67. The Impact of Low-Dose Cranial Boost on the Long-Term Outcomes of Adult Patients with High-Risk Acute Lymphoblastic Leukemia Undergoing Total Body Irradiation and Allogeneic Hematopoietic Stem Cell Transplantation.
Famoso JM; Grow JL; Laughlin B; Katsanis E; Stea B
Pract Radiat Oncol; 2019 May; 9(3):e283-e289. PubMed ID: 30578956
[TBL] [Abstract][Full Text] [Related]
68. Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era.
Chen H; Liu KY; Xu LP; Chen YH; Zhang XH; Wang Y; Qin YZ; Liu YR; Lai YY; Huang XJ
Leuk Res; 2017 Aug; 59():136-141. PubMed ID: 28654842
[TBL] [Abstract][Full Text] [Related]
69. How I treat long-term survivors of childhood acute leukemia.
Saultier P; Michel G
Blood; 2024 May; 143(18):1795-1806. PubMed ID: 38227937
[TBL] [Abstract][Full Text] [Related]
70. Quality of life and chronic health conditions in childhood acute leukaemia survivors.
Corella Aznar EG; Ayerza Casas A; Carboné Bañeres A; Calvo Escribano MÁC; Labarta Aizpún JI; Samper Villagrasa P
Med Clin (Barc); 2019 Mar; 152(5):167-173. PubMed ID: 30017209
[TBL] [Abstract][Full Text] [Related]
71. Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Ram R; Storb R; Sandmaier BM; Maloney DG; Woolfrey A; Flowers ME; Maris MB; Laport GG; Chauncey TR; Lange T; Langston AA; Storer B; Georges GE
Haematologica; 2011 Aug; 96(8):1113-20. PubMed ID: 21508120
[TBL] [Abstract][Full Text] [Related]
72. Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study.
Desjonquères A; Chevallier P; Thomas X; Huguet F; Leguay T; Bernard M; Bay JO; Tavernier E; Charbonnier A; Isnard F; Hunault M; Turlure P; Renaud M; Bastié JN; Himberlin C; Lepretre S; Lioure B; Lhéritier V; Asnafi V; Beldjord K; Lafage-Pochitaloff M; Béné MC; Ifrah N; Dombret H
Blood Cancer J; 2016 Dec; 6(12):e504. PubMed ID: 27935576
[TBL] [Abstract][Full Text] [Related]
73. Late effects in survivors of childhood acute lymphoblastic leukemia: a study from Thai Pediatric Oncology Group.
Pakakasama S; Veerakul G; Sosothikul D; Chainansamit SO; Laosombat V; Thanarattanakorn P; Lumkul R; Wiangnon S; Wangruangsathit S; Narkbunnam N; Kanjanapongkul S
Int J Hematol; 2010 Jun; 91(5):850-4. PubMed ID: 20490729
[TBL] [Abstract][Full Text] [Related]
74. Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial.
Bader P; Kreyenberg H; von Stackelberg A; Eckert C; Salzmann-Manrique E; Meisel R; Poetschger U; Stachel D; Schrappe M; Alten J; Schrauder A; Schulz A; Lang P; Müller I; Albert MH; Willasch AM; Klingebiel TE; Peters C
J Clin Oncol; 2015 Apr; 33(11):1275-84. PubMed ID: 25605857
[TBL] [Abstract][Full Text] [Related]
75. The outcome of allogeneic hematopoietic stem cell transplants without total body irradiation in pediatric patients with acute lymphoblastic leukemia: single centre experience.
Hamidieh A; Kargar M; Jahani M; Alimoghaddam K; Bahar B; Mousavi SA; Iravani M; Jalali A; Jalili M; Ghavamzadeh A
J Pediatr Hematol Oncol; 2012 Mar; 34(2):101-7. PubMed ID: 22367385
[TBL] [Abstract][Full Text] [Related]
76. Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia.
Varda-Bloom N; Danylesko I; Shouval R; Eldror S; Lev A; Davidson J; Rosenthal E; Volchek Y; Shem-Tov N; Yerushalmi R; Shimoni A; Somech R; Nagler A
Oncotarget; 2017 Jan; 8(1):418-429. PubMed ID: 27880933
[TBL] [Abstract][Full Text] [Related]
77. Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience.
Hallböök H; Hägglund H; Stockelberg D; Nilsson PG; Karlsson K; Björkholm M; Linderholm M; Wahlin A; Linder O; Smedmyr B;
Bone Marrow Transplant; 2005 Jun; 35(12):1141-8. PubMed ID: 15834433
[TBL] [Abstract][Full Text] [Related]
78. A cross-sectional follow-up study of physical morbidities, neurocognitive function, and attention problems in post-treatment childhood acute lymphoblastic leukemia survivors.
Chiou SS; Lin PC; Liao YM; Yang P
Kaohsiung J Med Sci; 2019 Jun; 35(6):373-378. PubMed ID: 30913362
[TBL] [Abstract][Full Text] [Related]
79. The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Hong Y; Zhao X; Qin Y; Zhou S; Chang Y; Wang Y; Zhang X; Xu L; Huang X
Ann Hematol; 2018 Sep; 97(9):1547-1554. PubMed ID: 29705861
[TBL] [Abstract][Full Text] [Related]
80. Stem cell transplantation outcomes in lymphoblastic lymphoma.
Brammer JE; Khouri I; Marin D; Ledesma C; Rondon G; Ciurea SO; Nieto Y; Champlin RE; Hosing C; Kebriaei P
Leuk Lymphoma; 2017 Feb; 58(2):366-371. PubMed ID: 27348707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
